BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 646538)

  • 1. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy.
    Abeles M; Urman JD; Rothfield NF
    Arch Intern Med; 1978 May; 138(5):750-4. PubMed ID: 646538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE.
    Dimant J; Ginzler EM; Diamond HS; Schlesinger M; Marino CT; Weiner M; Kaplan D
    J Rheumatol; 1978; 5(2):136-41. PubMed ID: 671430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation.
    Weiner ES; Abeles M
    J Rheumatol; 1989 May; 16(5):604-8. PubMed ID: 2666654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Chaudhry-Ahluwalia V; Hallet DC; Cook RJ
    J Rheumatol; 2001 Apr; 28(4):761-5. PubMed ID: 11327247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for osteonecrosis in systemic lupus erythematosus.
    Mont MA; Glueck CJ; Pacheco IH; Wang P; Hungerford DS; Petri M
    J Rheumatol; 1997 Apr; 24(4):654-62. PubMed ID: 9101497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Damage in systemic lupus erythematosus and its association with corticosteroids.
    Zonana-Nacach A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus and avascular bone necrosis.
    Nilsen KH
    N Z Med J; 1977 Jun; 85(589):472-5. PubMed ID: 271846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Avascular (aseptic) bone necrosis in SLE and nephrotic syndrome following corticosteroid therapy (author's transl)].
    Inage H; Koyama A; Narita M; Tojo S; Iesato K; Takei I; Wakasin Y; Wakasin M
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):393-9. PubMed ID: 7401392
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple osteonecrotic lesions in systemic lupus erythematosus.
    Fishel B; Caspi D; Eventov I; Avrahami E; Yaron M
    J Rheumatol; 1987 Jun; 14(3):601-4. PubMed ID: 3625643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.
    Nakamura J; Harada Y; Oinuma K; Iida S; Kishida S; Takahashi K
    Lupus; 2010 Oct; 19(11):1307-14. PubMed ID: 20605878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accrual of organ damage over time in patients with systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
    J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patellar tendon rupture in systemic lupus erythematosus.
    Pritchard CH; Berney S
    J Rheumatol; 1989 Jun; 16(6):786-8. PubMed ID: 2778760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
    Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
    Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aseptic bone necrosis in lupus disease].
    Pilosof T; Andreev T
    Vutr Boles; 1978; 17(5):84-92. PubMed ID: 716375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
    Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
    J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteonecrosis in systemic lupus erythematosus. Report of 3 cases].
    Marrón A; Formiga F; Valverde J; Mitjavila F; Pac M; Moga I
    An Med Interna; 1997 Jun; 14(6):307-9. PubMed ID: 9410105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.